|
|
|
Insider
Information: |
Winger Dennis L |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
288,465 |
|
Indirect Shares
|
11,500 |
|
|
Direct
Value |
$3,785,547 |
|
|
Indirect Value
|
$2,966,060 |
|
|
Total
Shares |
299,965 |
|
|
Total
Value |
$6,751,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Applera-Applied Biosys |
ABI |
Senior Vice President ... |
2008-11-21 |
0 |
2003-07-11 |
0 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
Director |
2006-08-11 |
69,544 |
2003-07-25 |
0 |
Premium* |
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2012-03-09 |
6,500 |
2010-02-16 |
6,500 |
Premium* |
|
Accuray Inc |
ARAY |
Director |
2017-11-30 |
162,181 |
2010-11-30 |
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2018-08-21 |
42,750 |
2018-08-21 |
5,000 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2017-06-14 |
7,490 |
2014-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2014-12-05 |
4 |
B |
$94.54 |
$250,058 |
D/D |
2,645 |
2,645 |
2.39 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-13 |
4 |
S |
$61.04 |
$1,045,310 |
D/D |
(17,125) |
59,875 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-21 |
4 |
S |
$60.30 |
$904,500 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-14 |
4 |
S |
$60.15 |
$1,030,069 |
D/D |
(17,125) |
42,750 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-08-17 |
4 |
S |
$59.62 |
$894,300 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-03-09 |
4 |
D |
$41.65 |
$1,613,938 |
D/D |
(38,750) |
6,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2010-02-16 |
4 |
B |
$38.54 |
$250,510 |
I/I |
6,500 |
6,500 |
2.1 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2006-12-06 |
4 |
OE |
$37.52 |
$250,000 |
D/D |
6,664 |
73,965 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2006-12-06 |
4 |
D |
$37.52 |
$250,000 |
D/D |
(6,664) |
67,301 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-01 |
4 |
S |
$36.75 |
$161,324 |
D/D |
(4,369) |
75,018 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-01 |
4 |
S |
$36.42 |
$221,468 |
D/D |
(6,054) |
68,964 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2008-08-21 |
4 |
D |
$36.24 |
$347,505 |
D/D |
(9,589) |
68,283 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-01 |
4 |
S |
$36.22 |
$75,481 |
D/D |
(2,077) |
66,887 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-02 |
4 |
S |
$36.18 |
$386,012 |
D/D |
(10,629) |
68,758 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-05 |
4 |
S |
$36.00 |
$360,314 |
D/D |
(9,981) |
69,406 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-02 |
4 |
S |
$35.98 |
$67,606 |
D/D |
(1,871) |
66,887 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-06 |
4 |
S |
$35.98 |
$408,733 |
D/D |
(11,297) |
68,090 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-06 |
4 |
S |
$35.88 |
$43,233 |
D/D |
(1,203) |
66,887 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-11-05 |
4 |
S |
$35.86 |
$90,591 |
D/D |
(2,519) |
66,887 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-02-01 |
4 |
S |
$34.42 |
$246,198 |
D/D |
(7,129) |
72,372 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-02-01 |
4 |
S |
$34.18 |
$174,057 |
D/D |
(5,071) |
67,301 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2012-03-09 |
4 |
A |
$34.05 |
$1,323,238 |
D/D |
38,750 |
45,250 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-02-02 |
4 |
S |
$33.90 |
$139,436 |
D/D |
(4,084) |
75,417 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-02-02 |
4 |
S |
$33.68 |
$274,328 |
D/D |
(8,116) |
67,301 |
0 |
- |
|
ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
|
2007-02-05 |
4 |
S |
$33.47 |
$366,544 |
D/D |
(10,921) |
68,580 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|